Hedge Fund and Insider Trading News: Warren Buffett, D. E. Shaw, Walleye Capital, Greenlight Capital, Citadel Investment Group, Elliott Management, Cassava Sciences Inc (SAVA), Biodesix Inc (BDSX), and More

Citadel’s Mewani Moves To Balyasny After $50 Million Loss (Bloomberg)

Warren Buffett Sold 6 Stocks In Q2. Here’s Why 1 Of Them Could Still Be A No-Brainer Buy. (The Motley Fool)

What D.E. Shaw’s First Human Fund Says About The Market (Bloomberg)

$12 Billion Walleye Will Back A New $500 Million Hedge Fund From A Former Millennium And Citadel Healthcare Portfolio Manager (Business Insider)

Colosseum Seeks Alpha From Short-Term Fluctuations (Hedge Nordic)

Greenlight Urges Brighthouse To Proceed With Aquarian Deal (Bloomberg)

Focus: Some PepsiCo Investors Cautious Of Elliott’s Plan To Spin Out Bottling (Reuters)

Shift Of Tactics In German Takeovers Thwarts Hedge Fund ‘Back End Trade’ (Financial Times)

Ex-BlackRock Executive Seeks $700 Million For Credit Hedge Fund (Bloomberg)

Crypto Hedge Fund Manager Henri Arslanian: ‘We’re Where Traditional Hedge Funds Were In Late 1990s’ (Financial News London)

Tuesday 9/23 Insider Buying Report: SAVA, BCDA (Nasdaq.com)

Schuler Buys Biodesix (BDSX) Shares Worth $999K (Investing.com)

You may be concerned about the recent declines in AI stocks such as NVDA. However, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than NVDA but trades at less than five times its earnings, check out our report about the cheapest AI stock. This stock has generated positive returns so far in 2025 despite the huge losses experienced by other AI stocks.